Final Analysis Of Safety And Exploratory Echo Data In A Phase 1, First-in-human, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study To Evaluate JK07 In Subjects With Heart Failure With Reduced Ejection FractionW.H. Wilson Tang, Samuel L. Murphy, Justin L. Grodin et al.|Journal of Cardiac Failure|2024Cited by 4
Single Ascending-Dose Study of Selective ErbB4 Agonist JK07 in Heart Failure With Reduced Ejection FractionWen Tang, Samuel L. Murphy, J. T. Steiner et al.|JACC Basic to Translational Science|2025Cited by 4
728 A phase 1/2 study of JK08, an IL-15 antibody fusion protein targeting CTLA-4, in patients with advanced solid tumorsNuria Kotecki, Naimish Pandya, Samuel L. Murphy et al.|Regular and Young Investigator Award Abstracts|2023Cited by 1